253 related articles for article (PubMed ID: 27707609)
1. The Treatment of Plasmodium knowlesi Malaria.
Barber BE; Grigg MJ; William T; Yeo TW; Anstey NM
Trends Parasitol; 2017 Mar; 33(3):242-253. PubMed ID: 27707609
[TBL] [Abstract][Full Text] [Related]
2. Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial.
Grigg MJ; William T; Menon J; Dhanaraj P; Barber BE; Wilkes CS; von Seidlein L; Rajahram GS; Pasay C; McCarthy JS; Price RN; Anstey NM; Yeo TW
Lancet Infect Dis; 2016 Feb; 16(2):180-188. PubMed ID: 26603174
[TBL] [Abstract][Full Text] [Related]
3. A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial).
Grigg MJ; William T; Dhanaraj P; Menon J; Barber BE; von Seidlein L; Rajahram G; Price RN; Anstey NM; Yeo TW
BMJ Open; 2014 Aug; 4(8):e006005. PubMed ID: 25138814
[TBL] [Abstract][Full Text] [Related]
4. Clinical management of Plasmodium knowlesi malaria.
Barber BE; Grigg MJ; Cooper DJ; van Schalkwyk DA; William T; Rajahram GS; Anstey NM
Adv Parasitol; 2021; 113():45-76. PubMed ID: 34620385
[TBL] [Abstract][Full Text] [Related]
5. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
[TBL] [Abstract][Full Text] [Related]
6. Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia.
William T; Menon J; Rajahram G; Chan L; Ma G; Donaldson S; Khoo S; Frederick C; Jelip J; Anstey NM; Yeo TW
Emerg Infect Dis; 2011 Jul; 17(7):1248-55. PubMed ID: 21762579
[TBL] [Abstract][Full Text] [Related]
7. Quantification of parasite clearance in Plasmodium knowlesi infections.
T Thurai Rathnam J; Grigg MJ; Dini S; William T; Sakam SS; Cooper DJ; Rajahram GS; Barber BE; Anstey NM; Haghiri A; Rajasekhar M; Simpson JA
Malar J; 2023 Feb; 22(1):54. PubMed ID: 36782162
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.
Visser BJ; Wieten RW; Kroon D; Nagel IM; Bélard S; van Vugt M; Grobusch MP
Malar J; 2014 Nov; 13():463. PubMed ID: 25428624
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium knowlesi: from Malaysia, a novel health care threat.
Sabbatani S; Fiorino S; Manfredi R
Infez Med; 2012 Mar; 20(1):5-11. PubMed ID: 22475654
[TBL] [Abstract][Full Text] [Related]
10. Artemisinin-based combination therapy for knowlesi malaria.
Ramharter M
Lancet Infect Dis; 2016 Feb; 16(2):134-6. PubMed ID: 26603170
[No Abstract] [Full Text] [Related]
11. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
[TBL] [Abstract][Full Text] [Related]
12. Clinical and laboratory features of human Plasmodium knowlesi infection.
Daneshvar C; Davis TM; Cox-Singh J; Rafa'ee MZ; Zakaria SK; Divis PC; Singh B
Clin Infect Dis; 2009 Sep; 49(6):852-60. PubMed ID: 19635025
[TBL] [Abstract][Full Text] [Related]
13. Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as Plasmodium malariae and delayed parenteral artesunate.
Rajahram GS; Barber BE; William T; Menon J; Anstey NM; Yeo TW
Malar J; 2012 Aug; 11():284. PubMed ID: 22905799
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
[TBL] [Abstract][Full Text] [Related]
15. Clinical and parasitological response to oral chloroquine and primaquine in uncomplicated human Plasmodium knowlesi infections.
Daneshvar C; Davis TM; Cox-Singh J; Rafa'ee MZ; Zakaria SK; Divis PC; Singh B
Malar J; 2010 Aug; 9():238. PubMed ID: 20723228
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium knowlesi malaria in children.
Barber BE; William T; Jikal M; Jilip J; Dhararaj P; Menon J; Yeo TW; Anstey NM
Emerg Infect Dis; 2011 May; 17(5):814-20. PubMed ID: 21529389
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis, Treatment, and Prevention of Malaria in the US: A Review.
Daily JP; Minuti A; Khan N
JAMA; 2022 Aug; 328(5):460-471. PubMed ID: 35916842
[TBL] [Abstract][Full Text] [Related]
18. Age-Related Clinical Spectrum of Plasmodium knowlesi Malaria and Predictors of Severity.
Grigg MJ; William T; Barber BE; Rajahram GS; Menon J; Schimann E; Piera K; Wilkes CS; Patel K; Chandna A; Drakeley CJ; Yeo TW; Anstey NM
Clin Infect Dis; 2018 Jul; 67(3):350-359. PubMed ID: 29873683
[TBL] [Abstract][Full Text] [Related]
19. Schizontocidal effects of oral artesunate on Plasmodium berghei in mice and P knowlesi in monkeys.
Shi YL; Li GF; Zhao JH; Yang JD; Ding DB
Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):755-8. PubMed ID: 10678113
[TBL] [Abstract][Full Text] [Related]
20. [The first monkey malaria in Turkey: a case of Plasmodium knowlesi].
Özbilgin A; Çavuş İ; Yıldırım A; Gündüz C
Mikrobiyol Bul; 2016 Jul; 50(3):484-90. PubMed ID: 27525405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
